Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Is nipple sparing mastectomy associated with increased complications, readmission and length of stay compared to skin sparing mastectomy?

Wang M, Huang J, Chagpar AB.

Am J Surg. 2019 Sep 13. pii: S0002-9610(19)31023-2. doi: 10.1016/j.amjsurg.2019.09.011. [Epub ahead of print]

PMID:
31540681
2.
3.

Resection of Cavity Shave Margins in Stage 0-III Breast Cancer Patients Undergoing Breast Conserving Surgery: A Prospective Multicenter Randomized Controlled Trial.

Dupont E, Tsangaris T, Garcia-Cantu C, Howard-McNatt M, Chiba A, Berger AC, Levine EA, Gass JS, Gallagher K, Lum SS, Martinez RD, Willis AI, Pandya SV, Brown EA, Fenton A, Mendiola A, Murray M, Solomon NL, Senthil M, Ollila DW, Edmonson D, Lazar M, Namm JP, Li F, Butler M, McGowan NE, Herrera ME, Avitan YP, Yoder B, Walters LL, McPartland T, Chagpar AB.

Ann Surg. 2019 Jul 8. doi: 10.1097/SLA.0000000000003449. [Epub ahead of print]

PMID:
31290763
4.

Impact of a Pre-Operative Exercise Intervention on Breast Cancer Proliferation and Gene Expression: Results from the Pre-Operative Health and Body (PreHAB) Study.

Ligibel JA, Dillon D, Giobbie-Hurder A, McTiernan A, Frank E, Cornwell M, Pun M, Campbell N, Dowling RJO, Chang MC, Tolaney S, Chagpar AB, Yung RL, Freedman RA, Dominici LS, Golshan M, Rhei E, Taneja K, Huang Y, Brown M, Winer EP, Jeselsohn R, Irwin ML.

Clin Cancer Res. 2019 Sep 1;25(17):5398-5406. doi: 10.1158/1078-0432.CCR-18-3143. Epub 2019 Apr 24.

PMID:
31018921
5.
6.

Defining Why the Re-excision Rate Dropped.

Chagpar AB.

Ann Surg Oncol. 2019 May;26(5):1176-1177. doi: 10.1245/s10434-019-07248-4. Epub 2019 Feb 24. No abstract available.

PMID:
30798449
7.

Reliability of Whole-Exome Sequencing for Assessing Intratumor Genetic Heterogeneity.

Shi W, Ng CKY, Lim RS, Jiang T, Kumar S, Li X, Wali VB, Piscuoglio S, Gerstein MB, Chagpar AB, Weigelt B, Pusztai L, Reis-Filho JS, Hatzis C.

Cell Rep. 2018 Nov 6;25(6):1446-1457. doi: 10.1016/j.celrep.2018.10.046.

8.

Reply: Complications in unilateral breast cancer patients who undergo contralateral prophylactic mastectomy versus unilateral mastectomy.

Huang J, Chagpar AB.

Surgery. 2019 Feb;165(2):486-496. doi: 10.1016/j.surg.2018.10.002. Epub 2018 Oct 29. No abstract available.

PMID:
30385125
9.

Breast cancer histopathology is predictive of low-risk Oncotype Dx recurrence score.

Wilson PC, Chagpar AB, Cicek AF, Bossuyt V, Buza N, Mougalian S, Killelea BK, Patel N, Harigopal M.

Breast J. 2018 Nov;24(6):976-980. doi: 10.1111/tbj.13117. Epub 2018 Sep 19.

PMID:
30230117
10.

Increased epigenetic age in normal breast tissue from luminal breast cancer patients.

Hofstatter EW, Horvath S, Dalela D, Gupta P, Chagpar AB, Wali VB, Bossuyt V, Storniolo AM, Hatzis C, Patwardhan G, Von Wahlde MK, Butler M, Epstein L, Stavris K, Sturrock T, Au A, Kwei S, Pusztai L.

Clin Epigenetics. 2018 Aug 29;10(1):112. doi: 10.1186/s13148-018-0534-8.

11.

How I treat breast cancer with positive lymph nodes.

Chagpar AB.

Clin Adv Hematol Oncol. 2018 Jul;16(7):486-490. Review. No abstract available.

PMID:
30067620
12.

Quality of Life and Body Image as a Function of Time from Mastectomy.

Huang J, Chagpar AB.

Ann Surg Oncol. 2018 Oct;25(10):3044-3051. doi: 10.1245/s10434-018-6606-3. Epub 2018 Jun 26.

PMID:
29947006
13.

Should Reexcision Rates in Breast Cancer Care be a Quality Measure?

Chagpar AB, Wilke LG.

Ann Surg Oncol. 2018 Oct;25(10):2818-2822. doi: 10.1245/s10434-018-6576-5. Epub 2018 Jun 26. No abstract available.

PMID:
29947002
14.

Do All Positive Margins in Breast Cancer Patients Undergoing a Partial Mastectomy Need to Be Resected?

Chagpar AB, Tsangaris TN, Lannin DR.

J Am Coll Surg. 2018 Jul;227(1):13-21. doi: 10.1016/j.jamcollsurg.2018.03.003. Epub 2018 Mar 8.

PMID:
29524664
15.

Controversies Regarding the Diagnosis and Management of Ductal Carcinoma In Situ.

Levinsohn E, Altman M, Chagpar AB.

Am Surg. 2018 Jan 1;84(1):1-6. Review.

PMID:
29428007
16.

Impacts of Early Guideline-Directed 21-Gene Recurrence Score Testing on Adjuvant Therapy Decision Making.

Dzimitrowicz H, Mougalian S, Storms S, Hurd S, Chagpar AB, Killelea BK, Horowitz NR, Lannin DR, Harigopal M, Hofstatter E, DiGiovanna MP, Adelson KB, Silber A, Abu-Khalaf M, Chung G, Zaheer W, Abdelghany O, Hatzis C, Pusztai L, Sanft TB.

J Oncol Pract. 2017 Dec;13(12):e1012-e1020. doi: 10.1200/JOP.2017.022731. Epub 2017 Oct 19.

PMID:
29048991
17.

Discussion of: "Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?"

Chagpar AB, Horowitz N, Sanft T, Wilson LD, Silber A, Killelea B, Moran MS, DiGiovanna MP, Hofstatter E, Chung G, Pusztai L, Lannin DR.

Am J Surg. 2017 Dec;214(6):1089-1090. doi: 10.1016/j.amjsurg.2017.09.025. Epub 2017 Sep 30. No abstract available.

PMID:
28987415
18.

On baseball and breast cancer.

Chagpar AB.

Am J Surg. 2018 Mar;215(3):353-356. doi: 10.1016/j.amjsurg.2017.09.004. Epub 2017 Sep 20.

PMID:
28958652
19.

Does lymph node status influence adjuvant therapy decision-making in women 70 years of age or older with clinically node negative hormone receptor positive breast cancer?

Chagpar AB, Horowitz N, Sanft T, Wilson LD, Silber A, Killelea B, Moran MS, DiGiovanna MP, Hofstatter E, Chung G, Pusztai L, Lannin DR.

Am J Surg. 2017 Dec;214(6):1082-1088. doi: 10.1016/j.amjsurg.2017.07.036. Epub 2017 Sep 18.

PMID:
28939252
20.

American Society of Clinical Oncology Multidisciplinary Cancer Management Course: Connecting Lives, Cancer Care, Education, and Compassion in Zimbabwe-A Pilot for Efforts of Sustainable Benefit?

Ndarukwa S, Nyakabau AM, Chagpar AB, Raben D, Ndlovu N, Kadzatsa W, Eaton VJ, Mafunda P, Razis E.

J Glob Oncol. 2016 Sep 14;3(4):409-417. doi: 10.1200/JGO.2016.003673. eCollection 2017 Aug.

21.

Association of LN Evaluation with Survival in Women Aged 70 Years or Older With Clinically Node-Negative Hormone Receptor Positive Breast Cancer.

Chagpar AB, Hatzis C, Pusztai L, DiGiovanna MP, Moran M, Mougalian S, Sanft T, Evans S, Hofstatter E, Wilson LD, Lannin DR.

Ann Surg Oncol. 2017 Oct;24(10):3073-3081. doi: 10.1245/s10434-017-5936-x. Epub 2017 Aug 1.

PMID:
28766195
22.

Can Tumor Biology Predict Occult Multifocal Disease in Breast Cancer Patients?

Chagpar AB, Cicek AF, Harigopal M.

Am Surg. 2017 Jul 1;83(7):704-708.

PMID:
28738939
23.

Regional variation in breast cancer surgery: Results from the National Cancer Database (NCDB).

Chiu AS, Thomas P, Killelea BK, Horowitz N, Chagpar AB, Lannin DR.

Am J Surg. 2017 Nov;214(5):907-913. doi: 10.1016/j.amjsurg.2017.07.008. Epub 2017 Jul 18.

PMID:
28736057
24.

Intraoperative Injection of Technetium-99m Sulfur Colloid for Sentinel Lymph Node Biopsy in Breast Cancer Patients: A Single Institution Experience.

Berrocal J, Saperstein L, Grube B, Horowitz NR, Chagpar AB, Killelea BK, Lannin DR.

Surg Res Pract. 2017;2017:5924802. doi: 10.1155/2017/5924802. Epub 2017 Apr 13.

25.

Sentinel lymph node biopsy in low risk settings.

Tasoulis MK, Hughes T, Babiera G, Chagpar AB.

Am J Surg. 2017 Sep;214(3):489-494. doi: 10.1016/j.amjsurg.2017.03.006. Epub 2017 Mar 15.

PMID:
28335989
26.

Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.

Hunt KK, Euhus DM, Boughey JC, Chagpar AB, Feldman SM, Hansen NM, Kulkarni SA, McCready DR, Mamounas EP, Wilke LG, Van Zee KJ, Morrow M.

Ann Surg Oncol. 2017 Feb;24(2):375-397. doi: 10.1245/s10434-016-5688-z. Epub 2016 Dec 8. Review.

PMID:
27933411
27.

Characteristics and treatment of human epidermal growth factor receptor 2 positive breast cancer: 43,485 cases from the National Cancer Database treated in 2010 and 2011.

Killelea BK, Chagpar AB, Horowitz NR, Lannin DR.

Am J Surg. 2017 Feb;213(2):426-432. doi: 10.1016/j.amjsurg.2016.05.018. Epub 2016 Jul 21.

PMID:
27769548
28.

Moving Toward Improved Teamwork in Cancer Care: The Role of Psychological Safety in Team Communication.

Jain AK, Fennell ML, Chagpar AB, Connolly HK, Nembhard IM.

J Oncol Pract. 2016 Nov;12(11):1000-1011. Epub 2016 Oct 24.

PMID:
27756800
29.
30.

Variation in Follow-up of Asymptomatic Breast Cancer Patients: Can We Choose More Wisely?

Chagpar AB, Hughes T, Hunt K, Aguirre J, Babiera G.

Am Surg. 2016 Aug;82(8):e188-90. No abstract available.

PMID:
27657562
31.

Do non-melanoma skin cancer survivors use tanning beds less often than the general public?

Wiznia L, Dai F, Chagpar AB.

Dermatol Online J. 2016 Aug 15;22(8). pii: 13030/qt75n111ds.

PMID:
27617935
32.

Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database.

Plasilova ML, Hayse B, Killelea BK, Horowitz NR, Chagpar AB, Lannin DR.

Medicine (Baltimore). 2016 Aug;95(35):e4614. doi: 10.1097/MD.0000000000004614.

33.

Racial Differences in Utilization of Breast Conservation Surgery: Results from the National Cancer Data Base (NCDB).

Thomas P, Killelea BK, Horowitz N, Chagpar AB, Lannin DR.

Ann Surg Oncol. 2016 Oct;23(10):3272-83. doi: 10.1245/s10434-016-5475-x. Epub 2016 Aug 8.

PMID:
27503494
34.

Quantitative assessment of the spatial heterogeneity of tumor-infiltrating lymphocytes in breast cancer.

Mani NL, Schalper KA, Hatzis C, Saglam O, Tavassoli F, Butler M, Chagpar AB, Pusztai L, Rimm DL.

Breast Cancer Res. 2016 Jul 29;18(1):78. doi: 10.1186/s13058-016-0737-x.

35.

Distress and quality of life in an ethnically diverse sample awaiting breast cancer surgery.

Rebholz WN, Cash E, Zimmaro LA, Bayley-Veloso R, Phillips K, Siwik C, Chagpar AB, Dhabhar FS, Spiegel D, Bell BS, Sephton SE.

J Health Psychol. 2018 Sep;23(11):1438-1451. doi: 10.1177/1359105316659916. Epub 2016 Jul 26.

PMID:
27466289
36.

Troubleshooting Sentinel Lymph Node Biopsy in Breast Cancer Surgery.

James TA, Coffman AR, Chagpar AB, Boughey JC, Klimberg VS, Morrow M, Giuliano AE, Harlow SP.

Ann Surg Oncol. 2016 Oct;23(11):3459-3466. doi: 10.1245/s10434-016-5432-8. Epub 2016 Jul 21.

37.

Contrary To Conventional Wisdom, Physicians Abandoned A Breast Cancer Treatment After A Trial Concluded It Was Ineffective.

Howard DH, Soulos PR, Chagpar AB, Mougalian S, Killelea B, Gross CP.

Health Aff (Millwood). 2016 Jul 1;35(7):1309-15. doi: 10.1377/hlthaff.2015.1490.

PMID:
27385249
38.

Reply to smoking cessation for patients with cancer: "The Emperor's New Clothes".

Ramaswamy AT, Toll B, Chagpar AB, Judson BL.

Cancer. 2016 Sep 15;122(18):2926. doi: 10.1002/cncr.30152. Epub 2016 Jun 10. No abstract available.

39.

Breast cancer biology varies by method of detection and may contribute to overdiagnosis.

Hayse B, Hooley RJ, Killelea BK, Horowitz NR, Chagpar AB, Lannin DR.

Surgery. 2016 Aug;160(2):454-62. doi: 10.1016/j.surg.2016.03.031. Epub 2016 May 27.

PMID:
27241117
40.

Economic Impact of Routine Cavity Margins Versus Standard Partial Mastectomy in Breast Cancer Patients: Results of a Randomized Controlled Trial.

Chagpar AB, Horowitz NR, Killelea BK, Tsangaris T, Longley P, Grizzle S, Loftus M, Li F, Butler M, Stavris K, Yao X, Harigopal M, Bossuyt V, Lannin DR, Pusztai L, Davidoff AJ, Gross CP.

Ann Surg. 2017 Jan;265(1):39-44. doi: 10.1097/SLA.0000000000001799.

41.

Variation in Practice of the Diagnostic Workup of Asymptomatic Patients Diagnosed with Invasive Breast Cancer.

Chagpar AB, Babiera GV, Aguirre J, Hunt KK, Hughes T.

Front Oncol. 2016 Mar 11;6:56. doi: 10.3389/fonc.2016.00056. eCollection 2016.

42.

Smoking, cessation, and cessation counseling in patients with cancer: A population-based analysis.

Ramaswamy AT, Toll BA, Chagpar AB, Judson BL.

Cancer. 2016 Apr 15;122(8):1247-53. doi: 10.1002/cncr.29851. Epub 2016 Feb 16.

43.

Cavity Shave Margins in Breast Cancer.

Chagpar AB; Trial investigators.

N Engl J Med. 2015 Nov 26;373(22):2187-8. doi: 10.1056/NEJMc1511344. No abstract available.

PMID:
26605934
44.

Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.

Killelea BK, Yang VQ, Wang SY, Hayse B, Mougalian S, Horowitz NR, Chagpar AB, Pusztai L, Lannin DR.

J Clin Oncol. 2015 Dec 20;33(36):4267-76. doi: 10.1200/JCO.2015.63.7801. Epub 2015 Nov 23.

PMID:
26598753
45.

Randomized Trial Comparing Telephone Versus In-Person Weight Loss Counseling on Body Composition and Circulating Biomarkers in Women Treated for Breast Cancer: The Lifestyle, Exercise, and Nutrition (LEAN) Study.

Harrigan M, Cartmel B, Loftfield E, Sanft T, Chagpar AB, Zhou Y, Playdon M, Li F, Irwin ML.

J Clin Oncol. 2016 Mar 1;34(7):669-76. doi: 10.1200/JCO.2015.61.6375. Epub 2015 Nov 23.

46.

Influence of a 21-Gene Recurrence Score Assay on Chemotherapy Delivery in Breast Cancer.

Rutter CE, Yao X, Mancini BR, Aminawung JA, Chagpar AB, Saglam O, Hofstatter EW, Abu-Khalaf M, Gross CP, Evans SB.

Clin Breast Cancer. 2016 Feb;16(1):59-62. doi: 10.1016/j.clbc.2015.09.008. Epub 2015 Sep 21.

PMID:
26483315
47.

Relationship between Complete Pathologic Response to Neoadjuvant Chemotherapy and Survival in Triple-Negative Breast Cancer.

Hatzis C, Symmans WF, Zhang Y, Gould RE, Moulder SL, Hunt KK, Abu-Khalaf M, Hofstatter EW, Lannin D, Chagpar AB, Pusztai L.

Clin Cancer Res. 2016 Jan 1;22(1):26-33. doi: 10.1158/1078-0432.CCR-14-3304. Epub 2015 Aug 18.

48.

Does three-dimensional intraoperative specimen imaging reduce the need for re-excision in breast cancer patients? A prospective cohort study.

Chagpar AB, Butler M, Killelea BK, Horowitz NR, Stavris K, Lannin DR.

Am J Surg. 2015 Nov;210(5):886-90. doi: 10.1016/j.amjsurg.2015.05.018. Epub 2015 Jul 18.

PMID:
26255230
49.

A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer.

Chagpar AB, Killelea BK, Tsangaris TN, Butler M, Stavris K, Li F, Yao X, Bossuyt V, Harigopal M, Lannin DR, Pusztai L, Horowitz NR.

N Engl J Med. 2015 Aug 6;373(6):503-10. doi: 10.1056/NEJMoa1504473. Epub 2015 May 30.

50.

Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States.

Mougalian SS, Soulos PR, Killelea BK, Lannin DR, Abu-Khalaf MM, DiGiovanna MP, Sanft TB, Pusztai L, Gross CP, Chagpar AB.

Cancer. 2015 Aug 1;121(15):2544-52. doi: 10.1002/cncr.29348. Epub 2015 Apr 22.

Supplemental Content

Loading ...
Support Center